Nuvectis Pharma, Inc.

NASDAQ:NVCT

Biotechnology

Healthcare
$19.20 +3.06%

+$0.39 today

Market cap
$660.27M
Beta
-0.07
P/E (TTM)
-11.2
EPS (TTM)
-$1.16
52W Low $5.55High $13.51

Volume 0.18M

Average 0.08M

NVCT Operating Margin

Operating income as a percentage of revenue, showing the profitability of core operations.

No reported Operating Margin figures are available to summarize.

Operating Margin history

Percent of revenue · from the income statement

No Operating Margin data reported for this period type.

Operating Margin vs competitors

How NVCT compares with its peers on the latest reported figures

NVCT Competitors Peer median
Operating Margin for NVCT and competitors
Company Period LTM level YoY 3-year change
MGNXMacroGenics, Inc.LTM Mar 2026-40.5% +24.7 pp+32.2 pp
NUVBNuvation Bio Inc.LTM Jun 2026-81.0% +1483.9 pp—
SNDXSyndax Pharmaceuticals, Inc.LTM Mar 2026-102.9% +683.7 pp—
VSTMVerastem, Inc.LTM Mar 2026-344.6% +966.2 pp+2259.3 pp
JANXJanux Therapeutics, Inc.LTM Mar 2026-726.3% +490.3 pp-797.6 pp
MREOMereo BioPharma Group plcLTM Mar 2026-7531.1% ——
NVCTNuvectis Pharma, Inc.FY2025— ——
ORICORIC Pharmaceuticals, Inc.FY2025— ——
IMMXImmix Biopharma, Inc.FY2025— ——
IMRXImmuneering CorporationFY2025— ——
CMPXCompass Therapeutics, Inc.FY2025— ——
Peer median (excluding NVCT) -223.7%+683.7 pp+32.2 pp

Competitors are the stored peer set for NVCT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00000
Gross Profit00000
Gross Margin—————
Research & Development9.55M13.23M15.38M12.92M18.15M
Selling, General & Admin3.35M6.01M7.52M6.93M9.42M
Operating Expenses12.89M19.23M22.9M19.85M27.57M
Depreciation & Amortization00000
EBITDA(12.89M)(19.09M)(22.26M)(19M)(26.44M)
EBITDA Margin—————
Operating Income(12.89M)(19.23M)(22.9M)(19.85M)(27.57M)
Operating Margin—————
Interest Income4K149K637K847K1.13M
Interest Expense00000
Other Income / Expenses4K149K637K847K1.13M
Income Before Tax(12.89M)(19.09M)(22.26M)(19M)(26.44M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(12.89M)(19.09M)(22.26M)(19M)(26.44M)
Net Margin—————
EPS (Basic)(1.09)(1.51)(1.43)(1.11)(1.32)
EPS (Diluted)(1.09)(1.51)(1.43)(1.11)(1.32)
Weighted Avg Shares12.72M12.66M15.56M17.11M21.81M
Weighted Avg Shares (Diluted)12.72M12.66M15.56M17.11M21.81M

Nuvectis Pharma, Inc.

NASDAQ:NVCT

Intrinsic Alpha fair value

Locked

Current Price

$19.20

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.